BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Dec 24, 2017; 7(6): 324-328
Published online Dec 24, 2017. doi: 10.5500/wjt.v7.i6.324
Elderly donor graft for liver transplantation: Never too late
Harleen Chela, Mohamad H Yousef, Abdelmajeed A Albarrak, Bhupinder S Romana, Dania N Hudhud, Veysel Tahan
Harleen Chela, Dania N Hudhud, Department of Internal Medicine, University of Missouri, Columbia, MO 65212, United States
Mohamad H Yousef, Abdelmajeed A Albarrak, Bhupinder S Romana, Veysel Tahan, Division of Gastroenterology and Hepatology, Missouri University, Columbia, MO 65212, United States
Author contributions: All authors contributed to the acquisition of data, writing and revision of this manuscript.
Conflict-of-interest statement: All the authors have no conflicts of interests to declare. All authors of this article declare that was no conflicting interests (including but not limited to commercial, personal, political, intellectual or religious interests) that are related to the work submitted for consideration of publication.
Correspondence to: Veysel Tahan, MD, FACP, FACG, FESBGH, Division of Gastroenterology and Hepatology, University of Missouri, 1 Hospital Dr., Columbia, MO 65212, United States. tahanv@health.missouri.edu
Telephone: +1-573-8846044 Fax: +1-573-8844595
Received: November 4, 2017
Peer-review started: November 5, 2017
First decision: November 20, 2017
Revised: November 27, 2017
Accepted: December 5, 2017
Article in press: December 6, 2017
Published online: December 24, 2017
Processing time: 47 Days and 18.1 Hours
Core Tip

Core tip: There is an increasing demand of livers for transplantation. Several studies showed successful results with elderly donors. We reviewed the aging process of the liver and the transplant outcomes of elderly donors. We highlight that elderly donors can be utilized given the extensive screening process allowing for risk factor analysis and appropriate allocation. Hence they should be used to allow for treatment of liver disease globally and help mitigate the shortage of hepatic grafts.